NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 124 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,310 | -58.1% | 111,505 | +1.5% | 0.00% | – |
| Q2 2023 | $284,520 | -17.0% | 109,853 | +30.7% | 0.00% | – |
| Q1 2023 | $342,867 | +25.3% | 84,036 | +54.2% | 0.00% | – |
| Q4 2022 | $273,626 | -48.7% | 54,507 | +33.8% | 0.00% | – |
| Q3 2022 | $533,000 | -70.5% | 40,734 | -71.1% | 0.00% | – |
| Q2 2022 | $1,806,000 | +190.4% | 140,882 | +245.5% | 0.00% | – |
| Q1 2022 | $622,000 | -23.6% | 40,782 | -11.3% | 0.00% | – |
| Q4 2021 | $814,000 | +17.1% | 45,986 | +39.2% | 0.00% | – |
| Q3 2021 | $695,000 | +176.9% | 33,025 | +159.2% | 0.00% | – |
| Q2 2021 | $251,000 | +21.3% | 12,742 | +78.9% | 0.00% | – |
| Q1 2021 | $207,000 | +8.4% | 7,123 | +12.6% | 0.00% | – |
| Q4 2020 | $191,000 | -83.0% | 6,326 | -91.0% | 0.00% | – |
| Q3 2020 | $1,123,000 | +308.4% | 70,561 | +405.7% | 0.00% | – |
| Q2 2020 | $275,000 | +276.7% | 13,953 | +136.7% | 0.00% | – |
| Q1 2020 | $73,000 | -74.9% | 5,895 | -62.6% | 0.00% | – |
| Q4 2019 | $291,000 | +977.8% | 15,761 | +717.1% | 0.00% | – |
| Q3 2019 | $27,000 | +35.0% | 1,929 | +44.5% | 0.00% | – |
| Q2 2019 | $20,000 | – | 1,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |